Literature DB >> 305199

An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia.

T K Ruebush, R A Weinstein, R L Baehner, D Wolff, M Bartlett, F Gonzles-Crussi, A J Sulzer, M G Schultz.   

Abstract

Between Jan 1 and Oct 31, 1975, a cluster of ten cases of pneumocystis pneumonia occurred in children with acute lymphocytic leukemia (ALL) at the James Whitcomb Riley Hospital for Children in Indianapolis. The risk of infection appeared to be related to the intensity of chemotherapy. Furthermore, illness developed in nine of the ten patients between 30 and 100 days after initiation of therapy, suggesting a period of heightened susceptibility to infection. An indirect immunofluorescent test was used to detect antipneumocystis antibodies in serum samples collected from patients with pneumocystis pneumonia and their contacts. Members of the Riley Hospital staff who had close contact with infected children had a higher prevalence of elevated antibody titers (7/12) than other staff members (2/22; P = .004) or parents of infected patients (0/8; P = .01). This suggests that transmission of pneumocystis may occur within the hospital environment.

Entities:  

Mesh:

Year:  1978        PMID: 305199     DOI: 10.1001/archpedi.1978.02120270041009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  18 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  AIDS and the lung: update 1992. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 3.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons.

Authors:  M S Bartlett; S H Vermund; R Jacobs; P J Durant; M M Shaw; J W Smith; X Tang; J J Lu; B Li; S Jin; C H Lee
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 5.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 6.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.

Authors:  C H Lee; J J Lu; M S Bartlett; M M Durkin; T H Liu; J Wang; B Jiang; J W Smith
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.

Authors:  M A Powles; D C McFadden; L A Pittarelli; D M Schmatz
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.

Authors:  P D Walzer; M E Rutledge
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.